Deontics Clinical Futures

Deontics named in key AI and HealthTech Gartner reports

Deontics attending Future Health Summit, Ireland

This week we were at the Future Health Summit in Dublin, to discuss the drive more personalised care in the digital age. It was great to hear from some of the leading lights in the digital health community and see what the future holds for healthcare.

Next Gen Clinical Pathway technology – Whitepaper

Clinical Pathways (CPs) are increasingly being perceived and used as a tool to improve quality of care, reduce unwarranted variation, and control costs. As their use increases, many challenges and potential barriers to pathway adoption are becoming apparent. The limitations of the current simple rule-based technologies, used to implement CPs often prevent the user from realising full potential of clinical pathways, and contribute to user pushback. Flexible, dynamic and unobtrusive implementation of CPs using cognitive decision-science and artificial intelligence based technologies can help to overcome many of these challenges.

Dr Vivek Patkar CMO, Deontics is talking on Deontics innovative clinical pathway modelling approach at WIN annual conference (24 January 2017) at Warwick university.

Download the white paper: Next Gen Clinical Pathways – Deontics

Deontics features in Global Digital Health 100 Award List for 2016

We are pleased to be featured in the Global Digital Health 100 Award List for 2016 – turn to page 8 of the Journal of mHealth. Over the past three years, the Global Digital Health 100 has become established as an international benchmark of industry activity for mobile, digital and connected technologies in healthcare

London Mayor Sadiq Khan welcomes Deontics to his International Business Program

Deontics has been announced as one of the latest hi-growth tech companies to join Mayor Sadiq Khan’s International Business Program. The program is designed to select and promote the fastest growing and most promising tech businesses in London. The program will see high growth businesses in the tech world such as Deontics supported at a range of global trade missions and events.

London Mayor Sadiq Khan said “London is one of the most vibrant and diverse places in the world to start and grow a technology business. These high growth companies have the potential to become the next global tech giants and I am delighted that they will join me in showing the world that London is open to talent, business and collaborations.”

Deontics has developed a world leading 4th generation Clinical Decision Support and Adaptive Clinical Pathway technology allowing fully dynamic, real time, implementation of adaptive clinical pathways at the point of care in primary, secondary and tertiary care settings. This improves clinical outcomes and patient safety and simultaneously reduces care costs.

Dr. Guy Wood-Gush, CEO of Deontics, said “Being selected for this program will accelerate our global growth and enable us to reach more customers who are looking to integrate ground breaking AI clinical solutions into their practices and products. London is at the forefront of this technology and we are delighted to be part of this program and to be recognised as leaders in this space.”


The Mayor’s International Business Programme, is a £5m programme part funded by the European Regional Development Fund (ERDF), aims to support high-growth companies in the life sciences, technology and urban sectors to increase their export success across a range of key markets in Europe, Asia and North America.

The three year programme is being led by London & Partners, the Mayor’s official promotional agency, in partnership with KPMG, PA Consulting, BDO, Benoy and London Chamber of Commerce and Industry.

For more information on Deontics contact Guy Wood-Gush,, or visit our website,